Zortress

From WikiMD.org
Jump to navigation Jump to search

Zortress

Zortress (/zɔːrˈtrɛs/), also known as Everolimus, is a medication used to prevent organ rejection in people who have received a kidney transplant or liver transplant. It is also used to treat certain types of cancer.

Etymology

The name "Zortress" is a brand name, and the generic name "Everolimus" is derived from the words "ever" and "limus". "Ever" is a reference to the drug's long-lasting effects, and "limus" is a Latin word meaning "limit" or "boundary", referring to the drug's ability to limit or inhibit the immune response.

Usage

Zortress is used to prevent the body's immune system from rejecting a transplanted organ. It works by suppressing the body's immune response, which reduces the risk of organ rejection. It is usually taken in combination with other medications to achieve the desired effect.

Related Terms

  • Immunosuppressant: A type of drug that reduces the body's immune response. Zortress is a type of immunosuppressant.
  • Transplant rejection: A process in which the body's immune system attacks a transplanted organ. Zortress is used to prevent transplant rejection.
  • mTOR inhibitor: A type of drug that inhibits the mTOR pathway, which is involved in cell growth and proliferation. Zortress is a type of mTOR inhibitor.

Side Effects

Common side effects of Zortress include fatigue, nausea, diarrhea, and swelling (edema). More serious side effects can include infection, kidney damage, and an increased risk of certain types of cancer.

See Also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski